{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,28]],"date-time":"2025-11-28T11:59:20Z","timestamp":1764331160527,"version":"3.37.3"},"reference-count":32,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T00:00:00Z","timestamp":1657238400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100010816","name":"Stiftelsen f\u00f6r Synskadade i f.d. Malm\u00f6hus l\u00e4n","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100010816","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011077","name":"Sk\u00e5nes universitetssjukhus","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100011077","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010810","name":"\u00d6gonfonden","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/100010810","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007687","name":"Svenska L\u00e4kares\u00e4llskapet","doi-asserted-by":"publisher","award":["-"],"award-info":[{"award-number":["-"]}],"id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003252","name":"Lund University","doi-asserted-by":"crossref","id":[{"id":"10.13039\/501100003252","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pediatr Rheumatol"],"published-print":{"date-parts":[[2022,12]]},"abstract":"<jats:title>Abstract<\/jats:title><jats:sec><jats:title>Background<\/jats:title><jats:p>A third follow-up study, mean 40.7\u2009years after uveitis onset, of a cohort originally consisting of 55 Swedish patients with uveitis associated with juvenile arthritis.<\/jats:p><\/jats:sec><jats:sec><jats:title>Method<\/jats:title><jats:p>A retrospective study of the patients\u2019 ophthalmic medical records. The results were compared to those of the same cohort previously studied at mean 7.2 and 24.0\u2009years after uveitis onset. In the present follow-up study, 30 of the original 55 patients consented to participate. Of these, 26 had ophthalmic medical records that were reviewed.<\/jats:p><\/jats:sec><jats:sec><jats:title>Results<\/jats:title><jats:p>In the 30 participants, active uveitis was seen in 43.4%, cataracts in 66.6% and glaucoma in 40.0%. When comparing data from previous follow-ups of the same cohort, a total of 61.8% were reported to have had cataracts at any of the three follow-ups, 29.0% had glaucoma or ocular hypertension and 12.7% had severe visual impairment in both eyes. At mean 40.7\u2009years after uveitis onset 20% of patients in the original uveitis cohort were deceased. In 4 of the 11 deceased individuals, rheumatic disease was stated as the main cause of death, and in 3 it was considered a contributory factor in the patients deaths.<\/jats:p><\/jats:sec><jats:sec><jats:title>Conclusions<\/jats:title><jats:p>Uveitis associated with juvenile arthritis can be active into midlife and possibly longer. Ocular complications and visual loss increased up to 40\u2009years after uveitis diagnosis. The mortality rate of this cohort was higher than that of a corresponding Swedish population. Lifelong ophthalmic check-ups are probably necessary for patients diagnosed with this type of uveitis.<\/jats:p><\/jats:sec>","DOI":"10.1186\/s12969-022-00704-8","type":"journal-article","created":{"date-parts":[[2022,7,8]],"date-time":"2022-07-08T11:03:06Z","timestamp":1657278186000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":5,"title":["Uveitis associated with juvenile arthritis: a continued cohort study 40\u2009years after uveitis onset"],"prefix":"10.1186","volume":"20","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0181-1692","authenticated-orcid":false,"given":"Angelika","family":"Skarin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabet","family":"Berthold","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ola","family":"Rauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Bengtsson-Stigmar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2022,7,8]]},"reference":[{"issue":"10","key":"704_CR1","first-page":"2275","volume":"30","author":"L Berntson","year":"2003","unstructured":"Berntson L, Andersson Gare B, Fasth A, Herlin T, Kristinsson J, Lahdenne P, et al. Incidence of juvenile idiopathic arthritis in the Nordic countries. A population based study with special reference to the validity of the ILAR and EULAR criteria. J Rheumatol. 2003;30(10):2275\u201382.","journal-title":"J Rheumatol"},{"issue":"1","key":"704_CR2","doi-asserted-by":"publisher","first-page":"218","DOI":"10.1186\/s13075-019-1994-8","volume":"21","author":"E Berthold","year":"2019","unstructured":"Berthold E, Mansson B, Kahn R. Outcome in juvenile idiopathic arthritis: a population-based study from Sweden. Arthritis Res Ther. 2019;21(1):218.","journal-title":"Arthritis Res Ther."},{"issue":"3","key":"704_CR3","doi-asserted-by":"publisher","first-page":"180","DOI":"10.3109\/09273948.2013.791701","volume":"21","author":"A Heiligenhaus","year":"2013","unstructured":"Heiligenhaus A, Heinz C, Edelsten C, Kotaniemi K, Minden K. Review for disease of the year: epidemiology of juvenile idiopathic arthritis and its associated uveitis: the probable risk factors. Ocul Immunol Inflamm. 2013;21(3):180\u201391.","journal-title":"Ocul Immunol Inflamm"},{"issue":"1","key":"704_CR4","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1002\/art.39323","volume":"68","author":"ML Krause","year":"2016","unstructured":"Krause ML, Crowson CS, Michet CJ, Mason T, Muskardin TW, Matteson EL. Juvenile idiopathic arthritis in Olmsted County, Minnesota, 1960-2013. Arthritis Rheumatol. 2016;68(1):247\u201354.","journal-title":"Arthritis Rheumatol"},{"issue":"6","key":"704_CR5","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1136\/ard.2004.026955","volume":"64","author":"K Kotaniemi","year":"2005","unstructured":"Kotaniemi K, Arkela-Kautiainen M, Haapasaari J, Leirisalo-Repo M. Uveitis in young adults with juvenile idiopathic arthritis: a clinical evaluation of 123 patients. Ann Rheum Dis. 2005;64(6):871\u20134.","journal-title":"Ann Rheum Dis"},{"issue":"1","key":"704_CR6","doi-asserted-by":"publisher","first-page":"66","DOI":"10.1186\/s12969-017-0195-8","volume":"15","author":"E Nordal","year":"2017","unstructured":"Nordal E, Rypdal V, Christoffersen T, Aalto K, Berntson L, Fasth A, et al. Incidence and predictors of uveitis in juvenile idiopathic arthritis in a Nordic long-term cohort study. Pediatr Rheumatol Online J. 2017;15(1):66.","journal-title":"Pediatr Rheumatol Online J"},{"issue":"2","key":"704_CR7","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1080\/09273940802650398","volume":"17","author":"A Skarin","year":"2009","unstructured":"Skarin A, Elborgh R, Edlund E, Bengtsson-Stigmar E. Long-term follow-up of patients with uveitis associated with juvenile idiopathic arthritis: a cohort study. Ocul Immunol Inflamm. 2009;17(2):104\u20138.","journal-title":"Ocul Immunol Inflamm"},{"issue":"11","key":"704_CR8","doi-asserted-by":"publisher","first-page":"1928","DOI":"10.1093\/rheumatology\/kex265","volume":"56","author":"D Dimopoulou","year":"2017","unstructured":"Dimopoulou D, Trachana M, Pratsidou-Gertsi P, Sidiropoulos P, Kanakoudi-Tsakalidou F, Dimitroulas T, et al. Predictors and long-term outcome in Greek adults with juvenile idiopathic arthritis: a 17-year continuous follow-up study. Rheumatology (Oxford). 2017;56(11):1928\u201338.","journal-title":"Rheumatology (Oxford)"},{"issue":"7","key":"704_CR9","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1111\/aos.13388","volume":"95","author":"M Papadopoulou","year":"2017","unstructured":"Papadopoulou M, Zetterberg M, Oskarsdottir S, Andersson GM. Assessment of the outcome of ophthalmological screening for uveitis in a cohort of Swedish children with juvenile idiopathic arthritis. Acta Ophthalmol. 2017;95(7):741\u20137.","journal-title":"Acta Ophthalmol"},{"issue":"5","key":"704_CR10","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1016\/j.jcjo.2017.01.011","volume":"52","author":"AM Kolomeyer","year":"2017","unstructured":"Kolomeyer AM, Crane ES, Tu Y, Liu D, Chu DS. Adult patients with uveitis associated with juvenile idiopathic arthritis: a retrospective review. Can J Ophthalmol. 2017;52(5):458\u201362.","journal-title":"Can J Ophthalmol"},{"issue":"9","key":"704_CR11","doi-asserted-by":"publisher","first-page":"1841","DOI":"10.1007\/s00417-016-3340-z","volume":"254","author":"M Oray","year":"2016","unstructured":"Oray M, Khachatryan N, Ebrahimiadib N, Abu Samra K, Lee S, Foster CS. Ocular morbidities of juvenile idiopathic arthritis-associated uveitis in adulthood: results from a tertiary center study. Graefes Arch Clin Exp Ophthalmol. 2016;254(9):1841\u20139.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"12","key":"704_CR12","doi-asserted-by":"publisher","first-page":"1444","DOI":"10.1093\/rheumatology\/41.12.1444","volume":"41","author":"JC Packham","year":"2002","unstructured":"Packham JC, Hall MA, Pimm TJ. Long-term follow-up of 246 adults with juvenile idiopathic arthritis: predictive factors for mood and pain. Rheumatology (Oxford). 2002;41(12):1444\u20139.","journal-title":"Rheumatology (Oxford)"},{"issue":"3","key":"704_CR13","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1034\/j.1600-0420.2003.00066.x","volume":"81","author":"M Zak","year":"2003","unstructured":"Zak M, Fledelius H, Pedersen FK. Ocular complications and visual outcome in juvenile chronic arthritis: a 25-year follow-up study. Acta Ophthalmol Scand. 2003;81(3):211\u20135.","journal-title":"Acta Ophthalmol Scand"},{"issue":"2","key":"704_CR14","doi-asserted-by":"publisher","first-page":"92","DOI":"10.4103\/ijo.IJO_869_16","volume":"65","author":"P Vashist","year":"2017","unstructured":"Vashist P, Senjam SS, Gupta V, Gupta N, Kumar A. Definition of blindness under National Programme for control of blindness: do we need to revise it? Indian J Ophthalmol. 2017;65(2):92\u20136.","journal-title":"Indian J Ophthalmol"},{"key":"704_CR15","unstructured":"Gare BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. I. Onset and disease process. J Rheumatol 1995;22(2):295\u2013307."},{"issue":"3","key":"704_CR16","doi-asserted-by":"publisher","first-page":"281","DOI":"10.1007\/s00417-005-0087-3","volume":"244","author":"PE Carvounis","year":"2006","unstructured":"Carvounis PE, Herman DC, Cha S, Burke JP. Incidence and outcomes of uveitis in juvenile rheumatoid arthritis, a synthesis of the literature. Graefes Arch Clin Exp Ophthalmol. 2006;244(3):281\u201390.","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"1","key":"704_CR17","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.survophthal.2012.04.006","volume":"58","author":"SS Siddique","year":"2013","unstructured":"Siddique SS, Suelves AM, Baheti U, Foster CS. Glaucoma and uveitis. Surv Ophthalmol. 2013;58(1):1\u201310.","journal-title":"Surv Ophthalmol"},{"issue":"17","key":"704_CR18","first-page":"289","volume":"116","author":"C Wolfram","year":"2019","unstructured":"Wolfram C, Schuster AK, Elflein HM, Nickels S, Schulz A, Wild PS, et al. The prevalence of visual impairment in the adult population. Dtsch Arztebl Int. 2019;116(17):289\u201395.","journal-title":"Dtsch Arztebl Int"},{"key":"704_CR19","doi-asserted-by":"publisher","first-page":"461078","DOI":"10.1155\/2014\/461078","volume":"2014","author":"A Moradi","year":"2014","unstructured":"Moradi A, Amin RM, Thorne JE. The role of gender in juvenile idiopathic arthritis-associated uveitis. J Ophthalmol. 2014;2014:461078.","journal-title":"J Ophthalmol"},{"issue":"10","key":"704_CR20","doi-asserted-by":"publisher","first-page":"e0164312","DOI":"10.1371\/journal.pone.0164312","volume":"11","author":"AJ Haasnoot","year":"2016","unstructured":"Haasnoot AJ, Vernie LA, Rothova A, VDD P, Los LI, Schalij-Delfos NE, et al. Impact of juvenile idiopathic arthritis associated uveitis in early adulthood. PLoS One. 2016;11(10):e0164312.","journal-title":"PLoS One"},{"issue":"1","key":"704_CR21","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1002\/acr.22649","volume":"68","author":"C Tappeiner","year":"2016","unstructured":"Tappeiner C, Schenck S, Niewerth M, Heiligenhaus A, Minden K, Klotsche J. Impact of Antiinflammatory treatment on the onset of uveitis in juvenile idiopathic arthritis: longitudinal analysis from a Nationwide pediatric rheumatology database. Arthritis Care Res (Hoboken). 2016;68(1):46\u201354.","journal-title":"Arthritis Care Res (Hoboken)"},{"issue":"2","key":"704_CR22","first-page":"308","volume":"22","author":"BA Gare","year":"1995","unstructured":"Gare BA, Fasth A. The natural history of juvenile chronic arthritis: a population based cohort study. II Outcome. J Rheumatol. 1995;22(2):308\u201319.","journal-title":"J Rheumatol"},{"issue":"2","key":"704_CR23","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1002\/art.27218","volume":"62","author":"PJ Hashkes","year":"2010","unstructured":"Hashkes PJ, Wright BM, Lauer MS, Worley SE, Tang AS, Roettcher PA, et al. Mortality outcomes in pediatric rheumatology in the US. Arthritis Rheum. 2010;62(2):599\u2013608.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"704_CR24","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1002\/1529-0131(200103)44:3<523::AID-ANR99>3.0.CO;2-1","volume":"44","author":"AR French","year":"2001","unstructured":"French AR, Mason T, Nelson AM, O'Fallon WM, Gabriel SE. Increased mortality in adults with a history of juvenile rheumatoid arthritis: a population-based study. Arthritis Rheum. 2001;44(3):523\u20137.","journal-title":"Arthritis Rheum"},{"issue":"3","key":"704_CR25","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/ar2669","volume":"11","author":"SE Gabriel","year":"2009","unstructured":"Gabriel SE, Michaud K. Epidemiological studies in incidence, prevalence, mortality, and comorbidity of the rheumatic diseases. Arthritis Res Ther. 2009;11(3):229.","journal-title":"Arthritis Res Ther"},{"issue":"5","key":"704_CR26","first-page":"958","volume":"30","author":"E Thomas","year":"2003","unstructured":"Thomas E, Symmons DP, Brewster DH, Black RJ, Macfarlane GJ. National study of cause-specific mortality in rheumatoid arthritis, juvenile chronic arthritis, and other rheumatic conditions: a 20 year followup study. J Rheumatol. 2003;30(5):958\u201365.","journal-title":"J Rheumatol"},{"issue":"7","key":"704_CR27","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1136\/annrheumdis-2017-212613","volume":"77","author":"T Beukelman","year":"2018","unstructured":"Beukelman T, Xie F, Chen L, Horton DB, Lewis JD, Mamtani R, et al. Risk of malignancy associated with paediatric use of tumour necrosis factor inhibitors. Ann Rheum Dis. 2018;77(7):1012\u20136.","journal-title":"Ann Rheum Dis"},{"issue":"9","key":"704_CR28","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1002\/acr.21709","volume":"64","author":"BL Nordstrom","year":"2012","unstructured":"Nordstrom BL, Mines D, Gu Y, Mercaldi C, Aquino P, Harrison MJ. Risk of malignancy in children with juvenile idiopathic arthritis not treated with biologic agents. Arthritis Care Res (Hoboken). 2012;64(9):1357\u201364.","journal-title":"Arthritis Care Res (Hoboken)."},{"issue":"12","key":"704_CR29","doi-asserted-by":"publisher","first-page":"3776","DOI":"10.1002\/art.27741","volume":"62","author":"JF Simard","year":"2010","unstructured":"Simard JF, Neovius M, Hagelberg S, Askling J. Juvenile idiopathic arthritis and risk of cancer: a nationwide cohort study. Arthritis Rheum. 2010;62(12):3776\u201382.","journal-title":"Arthritis Rheum"},{"issue":"4","key":"704_CR30","doi-asserted-by":"publisher","first-page":"760","DOI":"10.3899\/jrheum.100711","volume":"38","author":"S Bernatsky","year":"2011","unstructured":"Bernatsky S, Rosenberg AM, Oen KG, Duffy CM, Ramsey-Goldman R, Labrecque J, et al. Malignancies in juvenile idiopathic arthritis: a preliminary report. J Rheumatol. 2011;38(4):760\u20133.","journal-title":"J Rheumatol"},{"issue":"1","key":"704_CR31","doi-asserted-by":"publisher","first-page":"e000212","DOI":"10.1136\/rmdopen-2015-000212","volume":"2","author":"O Zahedi Niaki","year":"2016","unstructured":"Zahedi Niaki O, Clarke AE, Ramsey-Goldman R, Yeung R, Hayward K, Oen K, et al. Malignancy incidence in 5294 patients with juvenile arthritis. RMD Open. 2016;2(1):e000212.","journal-title":"RMD Open"},{"issue":"10","key":"704_CR32","doi-asserted-by":"publisher","first-page":"1339","DOI":"10.1136\/ard.2006.062760","volume":"66","author":"J Askling","year":"2007","unstructured":"Askling J, Fored CM, Brandt L, Baecklund E, Bertilsson L, Feltelius N, et al. Time-dependent increase in risk of hospitalisation with infection among Swedish RA patients treated with TNF antagonists. Ann Rheum Dis. 2007;66(10):1339\u201344.","journal-title":"Ann Rheum Dis"}],"container-title":["Pediatric Rheumatology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00704-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12969-022-00704-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12969-022-00704-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,11,24]],"date-time":"2023-11-24T10:33:38Z","timestamp":1700822018000},"score":1,"resource":{"primary":{"URL":"https:\/\/ped-rheum.biomedcentral.com\/articles\/10.1186\/s12969-022-00704-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,8]]},"references-count":32,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["704"],"URL":"https:\/\/doi.org\/10.1186\/s12969-022-00704-8","relation":{},"ISSN":["1546-0096"],"issn-type":[{"type":"electronic","value":"1546-0096"}],"subject":[],"published":{"date-parts":[[2022,7,8]]},"assertion":[{"value":"22 March 2022","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 June 2022","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"8 July 2022","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The study was performed in accordance with the Helsinki Declaration. It was approved by the Regional Ethical Review Board for southern Sweden (2017\/263) and the National Ethical Review Agency (2020\u201302134). Written consent to review ophthalmic medical records were received from all individuals participating in this study.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Not applicable.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors report no conflict of interests. The authors alone are responsible for the content and writing of this paper. AS has previously served as an advisor for Santen Pharma AB, Sweden and has given lectures funded by AbbVie AB, Sweden.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"47"}}